Sunovion CNS Development Canada Ulc
Pharmaceutical company · Toronto, Ontario, Canada
Sunovion CNS Development Canada Ulc is a pharmaceutical company headquartered in Toronto, Ontario, Canada. It has reported private securities offerings to the US SEC, most recently $17 million sold in a notice filed in 2015.
Profile compiled from public records. Is this your company? Request a correction or update
Sunovion CNS Development Canada Ulc at a glance
Typepharmaceutical company
HeadquartersToronto, Ontario, Canada
SEC industryPharmaceutical Preparations
SEC CIK1532079
What does Sunovion CNS Development Canada Ulc do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $16.8 million sold (2015).
Frequently asked questions about Sunovion CNS Development Canada Ulc
Where is Sunovion CNS Development Canada Ulc headquartered?
Sunovion CNS Development Canada Ulc is headquartered in Toronto, Ontario, Canada.
What does Sunovion CNS Development Canada Ulc do?
Sunovion CNS Development Canada Ulc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- ProMIS Neurosciences Inc.Toronto, Ontario, Canada
- Quantum Biopharma Ltd.Toronto, Ontario, Canada
- Psyence Biomedical Ltd.Toronto, Ontario, Canada
- Intellipharmaceutics International Inc.Toronto, Ontario, Canada
- Avicanna Inc.Toronto, Ontario, Canada
- Bradmer Pharmaceuticals IncToronto, Ontario, Canada
- Organigram Global Inc.Toronto, Ontario, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences